semaglutide pen injector Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled that delivers 2 mg per injection Images By activating GLP Wegovy 0.25 mg/0.5 mL pre-filled

Semaglutide is an injectable prescription medication that was originally approved for treating type 2 diabetes

These effects are particularly important to understand for patients with underlying digestive disorders like ulcerative colitis

At 48 weeks, a majority of participants on higher doses lost 15% of their body weight

Here are four high-risk drugdrug interactions that every clinician should recognize: Warfarin + NSAIDs Increased bleeding risk ACE inhibitors + Potassium-sparing diuretics Hyperkalemia Statins + Macrolide antibiotics Myopathy / Rhabdomyolysis SSRIs + MAO inhibitors Serotonin syndrome Early recognition, proper monitoring, and timely intervention can save lives

On December 22, 2025, the FDA approved oral Wegovy (semaglutide 25mg tablet) the first and only oral GLP-1 medication for chronic weight management

These are expected changes rather than harmful side effects